Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Restructuring Costs (2016 - 2020)

Historic Restructuring Costs for Avadel Pharmaceuticals (AVDL) over the last 6 years, with Q3 2020 value amounting to -$69000.0.

  • Avadel Pharmaceuticals' Restructuring Costs fell 10369.77% to -$69000.0 in Q3 2020 from the same period last year, while for Jun 2021 it was -$69000.0, marking a year-over-year decrease of 10457.86%. This contributed to the annual value of $3.3 million for FY2020, which is 29372.78% up from last year.
  • Avadel Pharmaceuticals' Restructuring Costs amounted to -$69000.0 in Q3 2020, which was down 10369.77% from $918000.0 recorded in Q2 2020.
  • In the past 5 years, Avadel Pharmaceuticals' Restructuring Costs ranged from a high of $23.9 million in Q2 2016 and a low of -$13.2 million during Q2 2017
  • In the last 5 years, Avadel Pharmaceuticals' Restructuring Costs had a median value of -$69000.0 in 2020 and averaged $31157.9.
  • The largest annual percentage gain for Avadel Pharmaceuticals' Restructuring Costs in the last 5 years was 14257.64% (2018), contrasted with its biggest fall of 51039.66% (2018).
  • Over the past 5 years, Avadel Pharmaceuticals' Restructuring Costs (Quarter) stood at -$3.7 million in 2016, then skyrocketed by 74.81% to -$933000.0 in 2017, then crashed by 510.4% to -$5.7 million in 2018, then soared by 34.06% to -$3.8 million in 2019, then soared by 98.16% to -$69000.0 in 2020.
  • Its Restructuring Costs was -$69000.0 in Q3 2020, compared to $918000.0 in Q2 2020 and $2.5 million in Q1 2020.